Related Experiment Videos
Arrhythmogenic actions of antiarrhythmic drugs
Abstract:
Cardiac arrhythmias may result from abnormalities of impulse propagation or abnormalities of impulse initiation. When arrhythmias are initiated by antiarrhythmic drugs, the most common mechanisms appear to be conduction block or reentry, and abnormal impulse initiation, which may be triggered by afterdepolarizations. The effects of drugs on conduction may result from their actions on the fast sodium channel, the slow calcium channel or their ability to prolong repolarization. The extent to which a drug that depresses fast sodium or slow calcium entry will exert its toxic effects depends in large part on its binding characteristics to its channel receptor site. Such toxicity represents a continuum for the therapeutic effects of these drugs. The factors that control drug access to binding sites, including lipid solubility, molecular size and extent of ionization, are reviewed, as are the contributions to conduction abnormalities of drug-induced changes in repolarization. The mechanisms whereby drugs induce abnormalities of impulse initiation are still a matter of conjecture. Apparently, drugs that increase inward plateau currents or decrease repolarizing potassium ion currents carry increased risk. Moreover, there is evidence for the role of early after depolarizations occurring secondary to prolonged repolarization as a possible cause of arrhythmias, including torsades de pointes. The mechanisms whereby antiarrhythmic drugs may contribute to this type of tachyarrhythmia are reviewed.
Insights
Antiarrhythmic drugs can cause cardiac arrhythmias through conduction block, reentry, or abnormal impulse initiation. Drug toxicity is linked to channel binding, influencing therapeutic effects and risks like torsades de pointes.
Area of Science:
- Cardiology
- Pharmacology
- Electrophysiology
Background:
- Cardiac arrhythmias stem from abnormal impulse propagation or initiation.
- Antiarrhythmic drugs can paradoxically cause arrhythmias via conduction block, reentry, or abnormal impulse initiation.
- Drug-induced arrhythmias are often linked to effects on ion channels and repolarization.
Purpose of the Study:
- To review the mechanisms by which antiarrhythmic drugs induce cardiac arrhythmias.
- To explore the relationship between drug binding characteristics, toxicity, and therapeutic effects.
- To examine the role of afterdepolarizations and prolonged repolarization in drug-induced arrhythmias.
Main Methods:
- Review of existing literature on antiarrhythmic drug mechanisms.
- Analysis of drug effects on cardiac ion channels (sodium, calcium, potassium).
- Examination of factors influencing drug-channel binding and access.
Main Results:
- Common drug-induced arrhythmia mechanisms include conduction block, reentry, and triggered activity by afterdepolarizations.
- Drug toxicity is a continuum of therapeutic effects, dependent on channel binding characteristics.
- Prolonged repolarization and early afterdepolarizations are implicated in arrhythmias like torsades de pointes.
Conclusions:
- Understanding drug-channel interactions is crucial for predicting and managing antiarrhythmic drug toxicity.
- Abnormal impulse initiation, potentially triggered by afterdepolarizations, is a significant concern with certain antiarrhythmic agents.
- Further research is needed to fully elucidate the mechanisms of drug-induced arrhythmias, particularly concerning impulse initiation.